29
ABL Bio
298380.KQ·KOSDAQDaejeon KRFounded 2016300 employees
Small CapbiotechPublicOncologyNeurology
Platform: Bispecific BBB
Market Cap
$1B
All Drugs
2
Clinical Trials
4
Failed / Terminated
1
FDA Approved
1
Stock Price & Catalysts (298380.KQ)
Loading 298380.KQ stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Capizanubrutinib | 298-3597 | Preclinical | 1 | KRASG12C | Ewing SarcomaCervical Ca | ||
| Nidatenlimab | 298-7289 | Approved | 3 | AHR | BCC |
SEC Filings & Financial Documents
SEC filings are not available for KOSDAQ-listed companies.
ABL Bio trades on KOSDAQ (KR). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (4)